Search

Your search keyword '"Akkerman, Onno"' showing total 455 results

Search Constraints

Start Over You searched for: Author "Akkerman, Onno" Remove constraint Author: "Akkerman, Onno"
455 results on '"Akkerman, Onno"'

Search Results

1. Patients and Medical Staff Attitudes Toward the Future Inclusion of eHealth in Tuberculosis Management: Perspectives From Six Countries Evaluated using a Qualitative Framework

4. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

8. Availability and costs of medicines for the treatment of tuberculosis in Europe

9. Rapid Diagnosis of XDR and Pre-XDR TB: A Systematic Review of Available Tools

10. Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

12. Strategies to Enhance Diagnostic Capabilities for the New Drug-Resistant Tuberculosis (DR-TB) Drugs.

13. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

14. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis

19. Tuberculosis impacts multiple aspects in quality of life in a Romanian cohort of drug‐susceptible and drug resistant patients: A patient‐reported outcome measures study

20. Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe

23. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020

26. Tuberculosis patients

30. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

36. Reply to Verhaeghe et al

37. Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

40. Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment

41. Identification of circulating monocytes as producers of tuberculosis disease biomarker C1q

43. Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis

47. Safety of Rifampicin at High Dose for Difficult-to-Treat Tuberculosis: Protocol for RIAlta Phase 2b/c Trial

48. Combining digital adherence technology and therapeutic drug monitoring for personalised tuberculosis care

50. Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease:A NTM-NET study

Catalog

Books, media, physical & digital resources